AI | pharmaphorum

AI

Patients

More than a discount: How intelligent copay programmes are r...

Brian Laird explains a more dynamic, data-driven approach to copay is redefining affordability, creating a new standard for balancing patient support.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

News

Lundbeck names AI head in quest to become 'bionic' company

Lundbeck has appointed Markus Kede to the newly created role of chief AI officer, charged with driving its ambition to become a 'bionic' company.

Digital

Accelerating the medical wheel with AI: From engagement to i...

Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.

Digital

AI's promise, biotech's peril: How unequal access to computi...

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

More than a discount: How intelligent copay programmes are r...

Augmented intelligence: The next-gen engine for biopharma in...

Making direct-to-patient work, with Matt Wadyka

Lundbeck names AI head in quest to become 'bionic' company

Accelerating the medical wheel with AI: From engagement to i...

AI's promise, biotech's peril: How unequal access to computi...

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks